[CYCC] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
15-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- 19.22%
YoY- 35.59%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 5 38 146 161 175 164 168 -90.29%
PBT -5,067 -3,572 -3,704 -3,123 -3,780 -3,571 -3,678 23.69%
Tax -637 -419 -127 -168 -122 -126 -126 193.12%
NP -4,764 -1,890 -3,577 -2,955 -3,658 -3,445 -3,552 21.51%
Tax Rate - - - - - - - -
Total Cost 4,769 1,928 3,723 3,116 3,833 3,609 3,720 17.92%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin -95,280.00 -4,973.68 -2,450.00 -1,835.40 -2,090.29 -2,100.61 -2,114.29 1151.83%
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS -149.01 -53.81 -101.86 -90.66 -113.25 -107.75 -128.11 10.54%
EPS Diluted -149.01 -53.81 -101.86 -90.66 -112.22 -107.75 -128.11 10.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.